Neurology Minute

Rituximab vs Ocrelizumab in Relapsing-Remitting Multiple Sclerosis

Informações:

Synopsis

Dr. Rae Bacharach discusses the paper, "Rituximab vs Ocrelizumab in Relapsing-Remitting Multiple Sclerosis". Show references: https://jamanetwork.com/journals/jamaneurology/article-abstract/2806000